Aldeyra Therapeutics (ALDX) Announces Clinically Meaningful Data from Sermatologic NS2 Study in SLS
Go back to Aldeyra Therapeutics (ALDX) Announces Clinically Meaningful Data from Sermatologic NS2 Study in SLS| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 3.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.93 | 52 Week High | $8.19 | |||
| Open | $3.93 | 52 Week Low | $3.39 | |||
| Day High | $3.93 | P/E | N/A | |||
| Day Low | $3.93 | EPS | $0.00 | |||
| Volume | 238 | |||||
